S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
McKesson Co. stock logo
MCK
McKesson
$518.81
-1.4%
$523.95
$352.34
$543.00
$68.18B0.45689,383 shs631,236 shs
Microsoft Co. stock logo
MSFT
Microsoft
$404.27
-1.8%
$415.48
$275.37
$430.82
$3.00T0.8921.87 million shs20.99 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.39
-0.2%
$27.19
$25.23
$40.56
$143.74B0.6142.48 million shs35.72 million shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
McKesson Co. stock logo
MCK
McKesson
-0.47%-0.77%-0.72%+6.68%+45.98%
Microsoft Co. stock logo
MSFT
Microsoft
-0.66%-2.70%-1.31%+4.56%+42.82%
Pfizer Inc. stock logo
PFE
Pfizer
-1.11%-3.42%-8.42%-9.56%-37.35%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
McKesson Co. stock logo
MCK
McKesson
4.8057 of 5 stars
2.45.03.33.02.82.52.5
Microsoft Co. stock logo
MSFT
Microsoft
4.502 of 5 stars
2.53.03.32.91.92.52.5
Pfizer Inc. stock logo
PFE
Pfizer
4.9926 of 5 stars
3.25.04.24.83.11.73.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
McKesson Co. stock logo
MCK
McKesson
2.83
Moderate Buy$533.502.83% Upside
Microsoft Co. stock logo
MSFT
Microsoft
2.92
Moderate Buy$432.136.89% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.35
Hold$36.8845.26% Upside

Current Analyst Ratings

Latest MCK, PFE, and MSFT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/18/2024
Microsoft Co. stock logo
MSFT
Microsoft
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$480.00 ➝ $475.00
4/17/2024
Microsoft Co. stock logo
MSFT
Microsoft
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$460.00 ➝ $480.00
4/15/2024
McKesson Co. stock logo
MCK
McKesson
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$522.00 ➝ $548.00
4/15/2024
Pfizer Inc. stock logo
PFE
Pfizer
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$45.00
4/12/2024
Microsoft Co. stock logo
MSFT
Microsoft
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$455.00 ➝ $465.00
4/11/2024
Microsoft Co. stock logo
MSFT
Microsoft
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$465.00 ➝ $520.00
4/10/2024
McKesson Co. stock logo
MCK
McKesson
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$510.00 ➝ $570.00
4/10/2024
Microsoft Co. stock logo
MSFT
Microsoft
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$500.00
4/10/2024
Microsoft Co. stock logo
MSFT
Microsoft
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$480.00
4/1/2024
Microsoft Co. stock logo
MSFT
Microsoft
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$465.00 ➝ $550.00
4/1/2024
Pfizer Inc. stock logo
PFE
Pfizer
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$45.00
(Data available from 4/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
McKesson Co. stock logo
MCK
McKesson
$276.71B0.25$31.63 per share16.40($10.99) per share-47.21
Microsoft Co. stock logo
MSFT
Microsoft
$211.92B14.18$11.44 per share35.34$27.76 per share14.56
Pfizer Inc. stock logo
PFE
Pfizer
$58.50B2.46$2.94 per share8.63$15.81 per share1.61

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
McKesson Co. stock logo
MCK
McKesson
$3.56B$22.0723.5116.721.430.99%-262.63%5.96%5/7/2024 (Confirmed)
Microsoft Co. stock logo
MSFT
Microsoft
$72.36B$11.0636.5530.742.2136.27%38.40%19.33%4/25/2024 (Confirmed)
Pfizer Inc. stock logo
PFE
Pfizer
$2.12B$0.3670.519.161.163.62%10.88%4.91%5/1/2024 (Confirmed)

Latest MCK, PFE, and MSFT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
McKesson Co. stock logo
MCK
McKesson
$6.39N/A-$6.39N/AN/AN/A  
5/1/2024N/A
Pfizer Inc. stock logo
PFE
Pfizer
$0.57N/A-$0.57N/AN/AN/A  
4/25/2024N/A
Microsoft Co. stock logo
MSFT
Microsoft
$2.81N/A-$2.81N/AN/AN/A    
2/7/2024Q3 2024
McKesson Co. stock logo
MCK
McKesson
$7.05$7.74+$0.69$11.06$77.93 billion$80.90 billion    
1/30/2024Q2 24
Microsoft Co. stock logo
MSFT
Microsoft
$2.76$2.93+$0.17$2.93$61.14 billion$62.02 billion    
1/30/202412/31/2023
Pfizer Inc. stock logo
PFE
Pfizer
-$0.19$0.10+$0.29$0.80$14.37 billion$14.25 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
McKesson Co. stock logo
MCK
McKesson
$2.480.48%+11.80%11.24%16 Years
Microsoft Co. stock logo
MSFT
Microsoft
$3.000.74%+10.11%27.12%22 Years
Pfizer Inc. stock logo
PFE
Pfizer
$1.686.62%+2.57%466.67%15 Years

Latest MCK, PFE, and MSFT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/12/2024
Microsoft Co. stock logo
MSFT
Microsoft
quarterly$0.750.72%5/15/20245/16/20246/13/2024
2/1/2024
McKesson Co. stock logo
MCK
McKesson
quarterly$0.620.5%2/29/20243/1/20244/1/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
McKesson Co. stock logo
MCK
McKesson
N/A
0.92
0.50
Microsoft Co. stock logo
MSFT
Microsoft
0.19
1.22
1.20
Pfizer Inc. stock logo
PFE
Pfizer
0.69
0.91
0.69

Ownership

Institutional Ownership

CompanyInstitutional Ownership
McKesson Co. stock logo
MCK
McKesson
85.07%
Microsoft Co. stock logo
MSFT
Microsoft
71.13%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%

Insider Ownership

CompanyInsider Ownership
McKesson Co. stock logo
MCK
McKesson
0.21%
Microsoft Co. stock logo
MSFT
Microsoft
0.03%
Pfizer Inc. stock logo
PFE
Pfizer
0.06%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
McKesson Co. stock logo
MCK
McKesson
51,000131.41 million131.13 millionOptionable
Microsoft Co. stock logo
MSFT
Microsoft
221,0007.43 billion7.43 billionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
88,0005.66 billion5.66 billionOptionable

MCK, PFE, and MSFT Headlines

SourceHeadline
Pfizer (NYSE:PFE) Hits New 1-Year Low at $25.26Pfizer (NYSE:PFE) Hits New 1-Year Low at $25.26
marketbeat.com - April 18 at 4:55 PM
Xponance Inc. Grows Position in Pfizer Inc. (NYSE:PFE)Xponance Inc. Grows Position in Pfizer Inc. (NYSE:PFE)
marketbeat.com - April 18 at 4:41 PM
Is Pfizer Stock A Sell As Shares Hit A 9-Year Low Amid The Search For Its Next Big Break?Is Pfizer Stock A Sell As Shares Hit A 9-Year Low Amid The Search For Its Next Big Break?
investors.com - April 18 at 1:01 PM
If Youd Invested $1,000 in Pfizer 5 Years Ago, Heres How Much Youd Have TodayIf You'd Invested $1,000 in Pfizer 5 Years Ago, Here's How Much You'd Have Today
fool.com - April 18 at 9:15 AM
Pfizer exec to join well-resourced venture capital firmPfizer exec to join well-resourced venture capital firm
thepharmaletter.com - April 18 at 9:10 AM
The 3 Most Overlooked Stocks Set for a Triple-Digit ComebackThe 3 Most Overlooked Stocks Set for a Triple-Digit Comeback
investorplace.com - April 17 at 5:48 PM
Pfizer-Connect Biopharma deal for anti-inflammatory agent endsPfizer-Connect Biopharma deal for anti-inflammatory agent ends
msn.com - April 17 at 2:42 PM
Pfizer Inc. (NYSE:PFE) Shares Acquired by KLCM Advisors Inc.Pfizer Inc. (NYSE:PFE) Shares Acquired by KLCM Advisors Inc.
marketbeat.com - April 17 at 1:39 PM
Pfizer (NYSE:PFE) Trading Down 0.8%Pfizer (NYSE:PFE) Trading Down 0.8%
marketbeat.com - April 17 at 12:42 PM
Connect Biopharma uncouples from Pfizer by scrapping long-standing eczema pactConnect Biopharma uncouples from Pfizer by scrapping long-standing eczema pact
fiercebiotech.com - April 17 at 9:42 AM
Pfizers academic-partnered R&D unit is scrapped as part of cost-cutting measuresPfizer's academic-partnered R&D unit is scrapped as part of cost-cutting measures
fiercebiotech.com - April 17 at 9:42 AM
HealthInvest Partners AB Acquires Shares of 42,820 Pfizer Inc. (NYSE:PFE)HealthInvest Partners AB Acquires Shares of 42,820 Pfizer Inc. (NYSE:PFE)
marketbeat.com - April 16 at 6:50 PM
Pfizers Doldrums, Just A Bad Case Of COVID-19?Pfizer's Doldrums, Just A Bad Case Of COVID-19?
seekingalpha.com - April 16 at 2:34 PM
Pfizer (NYSE:PFE) Stock Price Down 0.2%Pfizer (NYSE:PFE) Stock Price Down 0.2%
marketbeat.com - April 16 at 2:02 PM
Pfizers (PFE) Overweight Rating Reaffirmed at Cantor FitzgeraldPfizer's (PFE) Overweight Rating Reaffirmed at Cantor Fitzgerald
americanbankingnews.com - April 16 at 4:26 AM
Why the Market Dipped But Pfizer (PFE) Gained TodayWhy the Market Dipped But Pfizer (PFE) Gained Today
zacks.com - April 15 at 6:51 PM
Pfizer Eyeing Viking Therapeutics? A Scenario Among All The M&A TalkPfizer Eyeing Viking Therapeutics? A Scenario Among All The M&A Talk
seekingalpha.com - April 15 at 5:39 PM
Pfizer (NYSE:PFE) Trading Up 0.7%Pfizer (NYSE:PFE) Trading Up 0.7%
marketbeat.com - April 15 at 3:37 PM
A Closer Look at Pfizers Options Market DynamicsA Closer Look at Pfizer's Options Market Dynamics
benzinga.com - April 15 at 12:38 PM
Cullen Investment Group LTD. Takes Position in Pfizer Inc. (NYSE:PFE)Cullen Investment Group LTD. Takes Position in Pfizer Inc. (NYSE:PFE)
marketbeat.com - April 15 at 11:27 AM
Cantor Fitzgerald Reaffirms "Overweight" Rating for Pfizer (NYSE:PFE)Cantor Fitzgerald Reaffirms "Overweight" Rating for Pfizer (NYSE:PFE)
marketbeat.com - April 15 at 11:21 AM
Is Pfizer Stock a Buy?Is Pfizer Stock a Buy?
fool.com - April 15 at 8:45 AM
Pfizer’s Velsipity UK approval to raise competition in ulcerative colitis marketPfizer’s Velsipity UK approval to raise competition in ulcerative colitis market
biopharma-reporter.com - April 15 at 7:37 AM
Want $1,000 in Annual Dividend Income? Invest $13,200 in These Ultra-High-Yield Dividend Stocks.Want $1,000 in Annual Dividend Income? Invest $13,200 in These Ultra-High-Yield Dividend Stocks.
fool.com - April 15 at 4:53 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

McKesson logo

McKesson

NYSE:MCK
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment offers distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Microsoft logo

Microsoft

NASDAQ:MSFT
Microsoft Corporation develops and supports software, services, devices and solutions worldwide. The Productivity and Business Processes segment offers office, exchange, SharePoint, Microsoft Teams, office 365 Security and Compliance, Microsoft viva, and Microsoft 365 copilot; and office consumer services, such as Microsoft 365 consumer subscriptions, Office licensed on-premises, and other office services. This segment also provides LinkedIn; and dynamics business solutions, including Dynamics 365, a set of intelligent, cloud-based applications across ERP, CRM, power apps, and power automate; and on-premises ERP and CRM applications. The Intelligent Cloud segment offers server products and cloud services, such as azure and other cloud services; SQL and windows server, visual studio, system center, and related client access licenses, as well as nuance and GitHub; and enterprise services including enterprise support services, industry solutions, and nuance professional services. The More Personal Computing segment offers Windows, including windows OEM licensing and other non-volume licensing of the Windows operating system; Windows commercial comprising volume licensing of the Windows operating system, windows cloud services, and other Windows commercial offerings; patent licensing; and windows Internet of Things; and devices, such as surface, HoloLens, and PC accessories. Additionally, this segment provides gaming, which includes Xbox hardware and content, and first- and third-party content; Xbox game pass and other subscriptions, cloud gaming, advertising, third-party disc royalties, and other cloud services; and search and news advertising, which includes Bing, Microsoft News and Edge, and third-party affiliates. The company sells its products through OEMs, distributors, and resellers; and directly through digital marketplaces, online, and retail stores. The company was founded in 1975 and is headquartered in Redmond, Washington.
Pfizer logo

Pfizer

NYSE:PFE
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.